These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 33729626)

  • 1. Extracellular signal-regulated kinase regulates microglial immune responses in Alzheimer's disease.
    Chen MJ; Ramesha S; Weinstock LD; Gao T; Ping L; Xiao H; Dammer EB; Duong DD; Levey AI; Lah JJ; Seyfried NT; Wood LB; Rangaraju S
    J Neurosci Res; 2021 Jun; 99(6):1704-1721. PubMed ID: 33729626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early amyloid-induced changes in microglia gene expression in male APP/PS1 mice.
    Oshima T; Kater MSJ; Huffels CFM; Wesseling EM; Middeldorp J; Hol EM; Verheijen MHG; Smit AB; Boddeke EWGM; Eggen BJL
    J Neurosci Res; 2024 Mar; 102(3):e25295. PubMed ID: 38515329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease.
    Griciuc A; Patel S; Federico AN; Choi SH; Innes BJ; Oram MK; Cereghetti G; McGinty D; Anselmo A; Sadreyev RI; Hickman SE; El Khoury J; Colonna M; Tanzi RE
    Neuron; 2019 Sep; 103(5):820-835.e7. PubMed ID: 31301936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.
    Bundy JL; Vied C; Badger C; Nowakowski RS
    J Comp Neurol; 2019 Feb; 527(2):462-475. PubMed ID: 30291623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.
    Sudwarts A; Ramesha S; Gao T; Ponnusamy M; Wang S; Hansen M; Kozlova A; Bitarafan S; Kumar P; Beaulieu-Abdelahad D; Zhang X; Collier L; Szekeres C; Wood LB; Duan J; Thinakaran G; Rangaraju S
    Mol Neurodegener; 2022 May; 17(1):33. PubMed ID: 35526014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia changes associated to Alzheimer's disease pathology in aged chimpanzees.
    Edler MK; Sherwood CC; Meindl RS; Munger EL; Hopkins WD; Ely JJ; Erwin JM; Perl DP; Mufson EJ; Hof PR; Raghanti MA
    J Comp Neurol; 2018 Dec; 526(18):2921-2936. PubMed ID: 30069930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation.
    Dong W; Embury CM; Lu Y; Whitmire SM; Dyavarshetty B; Gelbard HA; Gendelman HE; Kiyota T
    J Neuroinflammation; 2016 Jul; 13(1):184. PubMed ID: 27401058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling.
    Li L; Wu XH; Zhao XJ; Xu L; Pan CL; Zhang ZY
    J Neuroinflammation; 2020 Feb; 17(1):61. PubMed ID: 32066466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.
    Wan W; Liu G; Li X; Liu Y; Wang Y; Pan H; Hu J
    Bioengineered; 2021 Dec; 12(2):12678-12690. PubMed ID: 34818971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
    Lee S; Xu G; Jay TR; Bhatta S; Kim KW; Jung S; Landreth GE; Ransohoff RM; Lamb BT
    J Neurosci; 2014 Sep; 34(37):12538-46. PubMed ID: 25209291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer's disease.
    Rayaprolu S; Gao T; Xiao H; Ramesha S; Weinstock LD; Shah J; Duong DM; Dammer EB; Webster JA; Lah JJ; Wood LB; Betarbet R; Levey AI; Seyfried NT; Rangaraju S
    Mol Neurodegener; 2020 May; 15(1):28. PubMed ID: 32381088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA let-7d-5p Alleviates Inflammatory Responses by Targeting Map3k1 and Inactivating ERK/p38 MAPK Signaling in Microglia.
    Fang F; Chen C
    Crit Rev Immunol; 2024; 44(6):13-25. PubMed ID: 38848290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
    Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
    Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.
    Gee MS; Son SH; Jeon SH; Do J; Kim N; Ju YJ; Lee SJ; Chung EK; Inn KS; Kim NJ; Lee JK
    Alzheimers Res Ther; 2020 Apr; 12(1):45. PubMed ID: 32317025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.
    Marsh SE; Abud EM; Lakatos A; Karimzadeh A; Yeung ST; Davtyan H; Fote GM; Lau L; Weinger JG; Lane TE; Inlay MA; Poon WW; Blurton-Jones M
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1316-25. PubMed ID: 26884167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
    Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
    J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.